On July 2, 2024, Fukuda Denshi Co., Ltd announced it held its Extraordinary General Meeting of Shareholders on June 27, 2024 and according to the results, the shareholder proposal by Japan Absolute Value Fund L.P. on, i) Election of 2 Directors: Appointment of Ms. Madoka Sato and Mr. Yusuke Nakamura, ii) Revise the amount of remuneration for Directors, iii) Remove the maximum amount of remuneration for outside directors were rejected.
FUKUDA DENSHI CO., LTD. is a Japan-based company mainly engaged in manufacture, purchase and sale of medical electronic equipment. The Company operates in four business segments. The Biopsy Device segment mainly involves in the manufacture, trading and sales of electrocardiographs, ultrasound diagnostic imaging equipment, automated hemocytometers, etc. The Biological Information Monitoring segment involves in the manufacture, trading and sale of biological information monitors. The Therapy Apparatus segment involves in the manufacture, trading and sale of defibrillators, ventilators, pacemakers, catheters, home rental business, etc. The Consumable Supplies and Others segment provides the consumable goods of equipment for all segments as well as repair and maintenance services.
FUKUDA DENSHI CO., LTD. 
